PEPTONIC medical AB (publ) (FRA:28L)

Market Cap	8.20M +256.5%
Revenue (ttm)	937.97K -47.7%
Net Income	-1.90M
EPS	-0.00
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Open	0.0002
Previous Close	0.0002
Day's Range	0.0002 - 0.0002
52-Week Range	0.0002 - 0.0016
Beta	n/a
Analysts	n/a
Price Target	n/a
Est. Earnings	Oct 30, 2026

About PEPTONIC medical AB

PEPTONIC medical AB (publ), a medical technology company, develops and sells intimate self-care products for women. The company offers products under the VagiVital brand, including a moisturizing gel for atrophy; an intimate calming gel for rapid relief of itching and irritation; moisturizing lubricant; a pH-balancing intimate wash/conditioner; self-test kits for diagnosing pre-menopause, menopause, vaginal infection, bacterial vaginosis, and amniotic fluid leakage; and gene test for diagnosing vaginal infection. It also provides VerniVia mouss...

• Industry: Pharmaceutical Preparations
• Founded: 2009
• Employees: 2
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 28L

Financial Performance

In 2025, PEPTONIC medical AB's revenue was 14.79 million, a decrease of -45.01% compared to the previous year's 26.89 million. Losses were -22.50 million, -62.53% less than in 2024.

Financial numbers in SEK

Data Sources: S&P Global Market Intelligence and Twelve Data

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Twelve Data.

Last checked:

Oct 26, 2026

Data Sources Report a data error